Asia Executives On The Move: Changes At Pfizer, Lilly, Alexion, Healios
Executive Summary
The coming of summer has brought a flurry of executive changes in the Asia-Pacific health sector. Pfizer China's head of R&D is leaving while Lilly and Alexion in Japan have new presidents.